Biosimilar Drugs
-
{
- All
- News
- Videos
-
India To Lead Global Pharma Landscape With Innovation-Driven Approach: Minister
- Monday April 13, 2026
- Health | Indo Asian Service News
India aims to lead global pharma with focus on biologics, biosimilars, and specialty medicines, says Health Minister JP Nadda.
-
www.ndtv.com
-
India Pharmaceutical Sector Aims To Make India A Global Innovation Hub In 2026
- Monday March 30, 2026
- Health | Indo-Asian News Service
New Delhi, March 30 (IANS) India’s pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry’s transition from volume-based growth to value and rese
-
www.ndtv.com
-
US Proposal Could Halve Biocon's Biosimilar Development Costs
- Friday November 14, 2025
- World News | Reuters
India's Biocon expects a 50% drop in costs for developing complex biosimilars as the United States has proposed to ease clinical testing for the drugs that make up more than 60% of its revenue, a top executive said on Wednesday.
-
www.ndtv.com
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
- Friday September 26, 2025
- World News | Edited by Sanstuti Nath
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
www.ndtv.com
-
India To Lead Global Pharma Landscape With Innovation-Driven Approach: Minister
- Monday April 13, 2026
- Health | Indo Asian Service News
India aims to lead global pharma with focus on biologics, biosimilars, and specialty medicines, says Health Minister JP Nadda.
-
www.ndtv.com
-
India Pharmaceutical Sector Aims To Make India A Global Innovation Hub In 2026
- Monday March 30, 2026
- Health | Indo-Asian News Service
New Delhi, March 30 (IANS) India’s pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry’s transition from volume-based growth to value and rese
-
www.ndtv.com
-
US Proposal Could Halve Biocon's Biosimilar Development Costs
- Friday November 14, 2025
- World News | Reuters
India's Biocon expects a 50% drop in costs for developing complex biosimilars as the United States has proposed to ease clinical testing for the drugs that make up more than 60% of its revenue, a top executive said on Wednesday.
-
www.ndtv.com
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
- Friday September 26, 2025
- World News | Edited by Sanstuti Nath
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
www.ndtv.com